LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Life story templates in dementia care: Ambiguous direction and purpose.

    Möllergren, Glenn / Harnett, Tove

    Dementia (London, England)

    2024  , Page(s) 14713012231224545

    Abstract: Background: The use of life stories in dementia care has been described as a way of seeing every person as an individual, looking beyond their dementia. Life stories have become synonymous with high-quality care, while in Sweden their mere existence in ... ...

    Abstract Background: The use of life stories in dementia care has been described as a way of seeing every person as an individual, looking beyond their dementia. Life stories have become synonymous with high-quality care, while in Sweden their mere existence in dementia care settings is taken to indicate quality in national comparisons. Such life stories are often standardised, generated by a family member answering predetermined questions in a template.
    Aim and methods: Using a constructionist approach, this study will (1) chart what versions of a person's life story the templates produce, and (2) establish the intended purpose of such life stories, as communicated by the templates. This study departs from the assumption that life story templates communicate something about the conceptions of people living with dementia. The thematic analysis used data comprising 30 blank templates, totalling about 1,700 questions.
    Findings: The life story templates were found to generate two very different versions of the individual: (1) a person before symptoms of dementia or (2) a patient
    Discussion: Despite strong pressure on dementia care providers to collect life stories from residents, the life story templates they use are without clear direction, ideology, or purpose. The lack of direction is key given that life stories can be considered actants that shape assumptions about people with dementia and construct realities in dementia care settings. We highlight the need to develop ethical guidelines for life story template design, matched with guidelines for their intended use.
    Language English
    Publishing date 2024-01-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2084045-7
    ISSN 1741-2684 ; 1471-3012
    ISSN (online) 1741-2684
    ISSN 1471-3012
    DOI 10.1177/14713012231224545
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Treatment of Community-Acquired Pneumonia: A Case Report and Current Treatment Dilemmas.

    Harnett, Glenn

    Case reports in emergency medicine

    2017  Volume 2017, Page(s) 5045087

    Abstract: Resistance to macrolides is rising in the USA and warrants careful consideration when confronted with a patient with suspected pneumonia in the urgent care clinic. This case study exemplifies the potentially serious consequences of treatment failure ... ...

    Abstract Resistance to macrolides is rising in the USA and warrants careful consideration when confronted with a patient with suspected pneumonia in the urgent care clinic. This case study exemplifies the potentially serious consequences of treatment failure following prescription of a macrolide for community-acquired bacterial pneumonia. Furthermore, the consequential treatment dilemmas currently faced by physicians are briefly discussed.
    Language English
    Publishing date 2017-06-15
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2684646-9
    ISSN 2090-6498 ; 2090-648X
    ISSN (online) 2090-6498
    ISSN 2090-648X
    DOI 10.1155/2017/5045087
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Exploring Workplace Testing with Real-Time Polymerase Chain Reaction SARS-CoV-2 Testing.

    Fuentes, Lucas / Shah, Nigam / Kelly, Sara / Harnett, Glenn / Schulman, Kevin A

    Journal of the American Board of Family Medicine : JABFM

    2022  Volume 35, Issue 1, Page(s) 96–101

    Abstract: Background: Molecular tests (ie, real-time polymerase chain reaction [RT-PCR]) and antigen tests are used to detect SARS-CoV-2. RT-PCR tests are generally considered to be the standard for clinical diagnosis of SARS-CoV-2 due to accuracy and reliability ...

    Abstract Background: Molecular tests (ie, real-time polymerase chain reaction [RT-PCR]) and antigen tests are used to detect SARS-CoV-2. RT-PCR tests are generally considered to be the standard for clinical diagnosis of SARS-CoV-2 due to accuracy and reliability but can take longer to return results than antigen tests. Our aim was to examine if point-of-care (POC) testing for SARS-CoV-2 infection would provide a flexible resource to help achieve workplace safety. We compared test results and time-to-test results between a POC RT-PCR test and a send-out PCR test in a program implemented in summer 2020.
    Results: POC testing shortened the time to results to 110 minutes in the POC setting from the 754 minutes for send-out tests. The specificity of POC RT-PCR single POC testing was 98.7% compared with send-out RT-PCR testing and was confirmed at 99.8% in a validation analysis. The sensitivity of the POC testing was 100% compared with send-out RT-PCR, although in a validation analysis, sensitivity appeared as 0% because only the 12 positive or indeterminate samples on the first analysis were retested and the majority were false-positives that were correctly ruled out.
    Conclusions: POC testing for SARS-CoV-2 with RT-PCR technology is possible at reduced time compared with send-out PCR testing.
    MeSH term(s) COVID-19 ; COVID-19 Testing ; Humans ; Real-Time Polymerase Chain Reaction ; Reproducibility of Results ; SARS-CoV-2 ; Sensitivity and Specificity ; Workplace
    Language English
    Publishing date 2022-01-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2239939-2
    ISSN 1558-7118 ; 1557-2625
    ISSN (online) 1558-7118
    ISSN 1557-2625
    DOI 10.3122/jabfm.2022.01.210284
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: It's about the patients: Practical antibiotic stewardship in outpatient settings in the United States.

    Amin, Alpesh N / Dellinger, E Patchen / Harnett, Glenn / Kraft, Bryan D / LaPlante, Kerry L / LoVecchio, Frank / McKinnell, James A / Tillotson, Glenn / Valentine, Salisia

    Frontiers in medicine

    2022  Volume 9, Page(s) 901980

    Abstract: Antibiotic-resistant pathogens cause over 35,000 preventable deaths in the United States every year, and multiple strategies could decrease morbidity and mortality. As antibiotic stewardship requirements are being deployed for the outpatient setting, ... ...

    Abstract Antibiotic-resistant pathogens cause over 35,000 preventable deaths in the United States every year, and multiple strategies could decrease morbidity and mortality. As antibiotic stewardship requirements are being deployed for the outpatient setting, community providers are facing systematic challenges in implementing stewardship programs. Given that the vast majority of antibiotics are prescribed in the outpatient setting, there are endless opportunities to make a smart and informed choice when prescribing and to move the needle on antibiotic stewardship. Antibiotic stewardship in the community, or "smart prescribing" as we suggest, should factor in antibiotic efficacy, safety, local resistance rates, and overall cost, in addition to patient-specific factors and disease presentation, to arrive at an appropriate therapy. Here, we discuss some of the challenges, such as patient/parent pressure to prescribe, lack of data or resources for implementation, and a disconnect between guidelines and real-world practice, among others. We have assembled an easy-to-use best practice guide for providers in the outpatient setting who lack the time or resources to develop a plan or consult lengthy guidelines. We provide specific suggestions for antibiotic prescribing that align real-world clinical practice with best practices for antibiotic stewardship for two of the most common bacterial infections seen in the outpatient setting: community-acquired pneumonia and skin and soft-tissue infection. In addition, we discuss many ways that community providers, payors, and regulatory bodies can make antibiotic stewardship easier to implement and more streamlined in the outpatient setting.
    Language English
    Publishing date 2022-07-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2022.901980
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Clinical Integration of a Highly Accurate Polymerase Chain Reaction Point-of-Care Test Can Inform Immediate Treatment Decisions for Chlamydia, Gonorrhea, and Trichomonas.

    Dawkins, Megan / Bishop, Lisa / Walker, Paula / Otmaskin, Danielle / Ying, Julia / Schmidt, Ryan / Harnett, Glenn / Abraham, Teresa / Gaydos, Charlotte A / Schoolnik, Gary / DiBenedetto, Kevin

    Sexually transmitted diseases

    2023  Volume 49, Issue 4, Page(s) 262–267

    Abstract: Background: Accurate same-day sexually transmitted infection (STI) diagnostic testing is generally unavailable, leading to syndromic management with high rates of overtreatment and undertreatment. We analyzed the ease of integration of the Visby STI ... ...

    Abstract Background: Accurate same-day sexually transmitted infection (STI) diagnostic testing is generally unavailable, leading to syndromic management with high rates of overtreatment and undertreatment. We analyzed the ease of integration of the Visby STI Panel into clinical practice, studied acceptance by patients and clinic personnel, and assessed the potential to inform accurate treatment decisions.
    Methods: In a cross-sectional single-visit study of 55 women aged 18 to 56 years, women self-collected vaginal swab samples that were analyzed using the Visby STI Panel for Chlamydia trachomatis, Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV). Results were compared with standard-of-care clinic results from send-out laboratory polymerase chain reaction tests. Surveys assessed patient and device operator experiences with the Visby STI Panel and clinicians' perceived need for and acceptance of the device. Time parameters were measured to evaluate the impact on clinical workflow, and syndromic treatment decisions were compared with anticipated treatment based on the Visby STI Panel results.
    Results: Patients strongly agreed that sample self-collection was easy, and operators reported the device easy to use. Clinicians valued the rapid return of results, and patients were comfortable waiting up to 30 minutes to receive them. In 13 of 15 cases, the Visby STI Panel correctly identified undertreated patients as infected and correctly identified all 33 incidences of overtreatment.
    Conclusions: Clinical adoption of the Visby STI Panel into primary care clinics and doctors' offices could reduce overtreatment and undertreatment of STIs. If integrated efficiently into the clinical workflow, the test would have minimal impact on staff time and visit duration for patients.
    MeSH term(s) Chlamydia Infections/diagnosis ; Chlamydia Infections/drug therapy ; Chlamydia Infections/epidemiology ; Chlamydia trachomatis/genetics ; Cross-Sectional Studies ; Female ; Gonorrhea/diagnosis ; Gonorrhea/drug therapy ; Gonorrhea/epidemiology ; Humans ; Male ; Neisseria gonorrhoeae/genetics ; Point-of-Care Testing ; Polymerase Chain Reaction ; Sexually Transmitted Diseases/diagnosis ; Sexually Transmitted Diseases/drug therapy ; Sexually Transmitted Diseases/epidemiology ; Trichomonas ; Trichomonas Infections/diagnosis ; Trichomonas Infections/drug therapy ; Trichomonas Infections/epidemiology ; Trichomonas vaginalis/genetics
    Language English
    Publishing date 2023-07-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 435191-5
    ISSN 1537-4521 ; 0148-5717
    ISSN (online) 1537-4521
    ISSN 0148-5717
    DOI 10.1097/OLQ.0000000000001586
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment.

    Shihabuddin, Bashar S / Faron, Matthew L / Relich, Ryan F / Van Heukelom, Paul / Mayne, Donna / Staat, Mary Allen / Selvarangan, Rangaraj / Hueschen, Leslie A / Wolk, Donna M / House, Stacey / Harnett, Glenn / McGann, Kevin / Steele, Mark T / Romero, Jose R / Arms, Joe / Lander, Owen / Loeffelholz, Michael / Strouts, Fiona / Cohen, Daniel

    Diagnostic microbiology and infectious disease

    2022  Volume 104, Issue 2, Page(s) 115764

    Abstract: The COVID-19 pandemic highlighted the significance of readily available and easily performed viral testing for surveillance during future infectious pandemics. The objectives of this study were: to assess the performance of the Xpert Xpress Flu and/or ... ...

    Abstract The COVID-19 pandemic highlighted the significance of readily available and easily performed viral testing for surveillance during future infectious pandemics. The objectives of this study were: to assess the performance of the Xpert Xpress Flu and/or RSV test, a multiplex PCR assay for detecting influenza A and B virus and respiratory syncytial virus nucleic acids in respiratory tract specimens, relative to the Quidel Lyra Influenza A+B assay and the Prodesse ProFlu+ assay, and the system's ease of use by minimally trained operators. Overall, the Xpert Xpress Flu/RSV test demonstrated a high positive and negative percent agreement with the comparator assays, and was easy to use and interpret results, based on the operators' feedback. We concluded that the Xpert Xpress Flu/RSV test is sensitive, specific, and easy to use for the diagnosis of influenza and RSV by minimally trained operators and can be a valuable tool in future infectious clusters or pandemics.
    MeSH term(s) COVID-19/diagnosis ; Humans ; Influenza A virus/genetics ; Influenza B virus/genetics ; Influenza, Human/diagnosis ; Molecular Diagnostic Techniques/methods ; Nasopharynx ; Pandemics ; Real-Time Polymerase Chain Reaction/methods ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Syncytial Virus, Human/genetics ; Sensitivity and Specificity
    Language English
    Publishing date 2022-07-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604920-5
    ISSN 1879-0070 ; 0732-8893
    ISSN (online) 1879-0070
    ISSN 0732-8893
    DOI 10.1016/j.diagmicrobio.2022.115764
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.

    Cohen, Daniel M / Kline, Jennifer / May, Larissa S / Harnett, Glenn Eric / Gibson, Jane / Liang, Stephen Y / Rafique, Zubaid / Rodriguez, Carina A / McGann, Kevin M / Gaydos, Charlotte A / Mayne, Donna / Phillips, David / Cohen, Jason

    Journal of clinical microbiology

    2018  Volume 56, Issue 2

    Abstract: The Xpert Flu+RSV Xpress Assay is a fast, ... ...

    Abstract The Xpert Flu+RSV Xpress Assay is a fast, automated
    MeSH term(s) Automation, Laboratory ; DNA, Viral/genetics ; Humans ; Influenza A virus/genetics ; Influenza A virus/isolation & purification ; Influenza B virus/genetics ; Influenza B virus/isolation & purification ; Influenza, Human/diagnosis ; Influenza, Human/virology ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Nasopharynx/virology ; Point-of-Care Systems ; Real-Time Polymerase Chain Reaction ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Syncytial Virus Infections/virology ; Respiratory Syncytial Virus, Human/genetics ; Respiratory Syncytial Virus, Human/isolation & purification ; Sensitivity and Specificity ; Time Factors
    Chemical Substances DNA, Viral
    Language English
    Publishing date 2018-01-24
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 390499-4
    ISSN 1098-660X ; 0095-1137
    ISSN (online) 1098-660X
    ISSN 0095-1137
    DOI 10.1128/JCM.01237-17
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The impact of respiratory syncytial virus infection on endothelin receptor function and release in sheep bronchial explants.

    Fernandes, Lynette B / D'Aprile, Angela C / Self, Glenn J / Harnett, Gerald B / Goldie, Roy G

    Journal of cardiovascular pharmacology

    2004  Volume 44 Suppl 1, Page(s) S202–6

    Abstract: We investigated the impact of respiratory syncytial virus (RSV) infection, an important asthma precipitant, on endothelin receptor function and release in sheep bronchial explants. RSV infection was confirmed using polymerase chain reaction and ... ...

    Abstract We investigated the impact of respiratory syncytial virus (RSV) infection, an important asthma precipitant, on endothelin receptor function and release in sheep bronchial explants. RSV infection was confirmed using polymerase chain reaction and immunohistochemistry. Since sheep airway smooth muscle contains only endothelin-A receptors, sarafotoxin (Stx) S6c did not cause airway contraction. In contrast, sarafotoxin S6c (300 nM) caused contraction in RSV-infected bronchial explants (8 +/- 3% carbachol Emax). However, we could not detect airway smooth muscle endothelin-B receptors in explants using autoradiography. RSV infection per se did not alter the release of immunoreactive endothelin from sheep bronchial explants (control = 11.6 +/- 0.9 pg versus RSV = 12.1 +/- 0.9 pg). Interestingly, dexamethasone (1 microM) alone increased endothelin release in both control (17.9 +/- 2.0 pg) and RSV-infected tissue (18.3 +/- 3.1 pg). The combined presence of protease-activated receptor-2 (PAR-2) ligand (100 microM) and dexamethasone (1 microM) also increased endothelin release from control tissue (17.3 +/- 1.4 pg), but endothelin release was suppressed by PAR-2 ligand in RSV-infected tissue (10.3 +/- 0.8 pg), probably because PAR-2 expression was increased by RSV. In summary, the novel expression of endothelin-B receptors triggered by RSV might be relevant to RSV-associated asthma. Furthermore, activation of airway PAR-2 may be protective in asthma where endothelin levels are elevated in part via endothelin release suppression.
    MeSH term(s) Animals ; Bronchi/drug effects ; Bronchi/metabolism ; Bronchi/physiopathology ; Bronchi/virology ; Culture Media, Conditioned/metabolism ; Dexamethasone/metabolism ; Dinoprostone/metabolism ; Dose-Response Relationship, Drug ; Endothelin-1/metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Indomethacin/pharmacology ; Male ; Muscle Contraction/drug effects ; Muscle, Smooth/drug effects ; Muscle, Smooth/metabolism ; Muscle, Smooth/physiopathology ; Muscle, Smooth/virology ; Oligopeptides/pharmacology ; Peptides, Cyclic/pharmacology ; Piperidines/pharmacology ; Receptor, Endothelin A/metabolism ; Receptor, Endothelin B/drug effects ; Receptor, Endothelin B/metabolism ; Receptor, PAR-2/metabolism ; Respiratory Syncytial Virus Infections/metabolism ; Respiratory Syncytial Virus Infections/physiopathology ; Sheep ; Time Factors ; Tissue Culture Techniques ; Viper Venoms/pharmacology
    Chemical Substances Culture Media, Conditioned ; Endothelin-1 ; Oligopeptides ; Peptides, Cyclic ; Piperidines ; Receptor, Endothelin A ; Receptor, Endothelin B ; Receptor, PAR-2 ; Viper Venoms ; sarafotoxins s6 ; BQ 788 (44OLL8XEJ4) ; Dexamethasone (7S5I7G3JQL) ; Dinoprostone (K7Q1JQR04M) ; cyclo(Trp-Asp-Pro-Val-Leu) (S2A8YZM151) ; Indomethacin (XXE1CET956)
    Language English
    Publishing date 2004-06-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 391970-5
    ISSN 1533-4023 ; 0160-2446
    ISSN (online) 1533-4023
    ISSN 0160-2446
    DOI 10.1097/01.fjc.0000166236.57077.9f
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top